2023-04-19 | NYSEAM:CVM | Press Release | Cel-Sci Corporation

(2023-04-19 | NYSEAM:CVM) CEL-SCI to Pursue Canada's Conditional Approval Pathway for Multikine in the Treatment of Head & Neck Cancer

Related Keywords

Vienna ,Wien ,Austria ,United States ,Baltimore ,Maryland ,Virginia ,Canada ,American ,Geert Kersten ,Health Canada ,Exchange Commission ,Securities Exchange ,Canada Closecurlyquote ,Leukocyte Interleukin Injection ,Conditions Closecurlydoublequote ,Biologics License Application ,Leukocyte Interleukin ,Orphan Drug ,Securities Act ,Securities Exchange Act ,Cel Sci Corporation ,Healthcare 37 ,Biotechnology 121 ,Usa 8 ,Biotechnology 70569 ,